Track the Milestone Pharmaceuticals Inc. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Milestone Pharmaceuticals Inc. has recorded 24 public disclosures. Market capitalisation: €144.4m. The latest transaction was filed on 20 April 2026 (Cession). Among the most active insiders: Oliveto Joseph. All data is accessible without an account.
24
Insider Decl.
n/a
Thresholds
€14m
6 ops.
Buy Volume
€70,972
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Milestone Pharmaceuticals Inc. Strong Buy (bullish), based on 6 analysts. Average price target: US$6.33.
43Σ signal
Buys €14m€70,972 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
8,016 shares@ US$1.120.0047% mcap100.0% of flowCommon SharesSEC:0001209191-22-033336:0
24 of 24 declarations
Acerca de Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades cardiovasculares. Cotiza en NASDAQ bajo el ticker MIST.